Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.
Journal: Journal of the National Cancer Institute
Published: September 27, 2014
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 08, 2014
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T.
Journal: Prostate cancer and prostatic diseases
Published: February 14, 2014
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancer.
Journal: Urology
Published: January 25, 2013
Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.
Journal: Journal of the National Cancer Institute
Published: July 25, 2012
Sipuleucel-T for the treatment of advanced prostate cancer.
Journal: Seminars in oncology
Published: May 19, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 22, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026